Also the β1AR has recently been demonstrated to enhance norepinephrine release, providing a plausible rational for the antihypertensive action of β1AR antagonists, the most frequently used β-blockers in the treatment of hypertension (Berg, 2014a). The gene discussed is ADRB1; the disease is hypertensive disorder.